Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 7;21(11):e3002351.
doi: 10.1371/journal.pbio.3002351. eCollection 2023 Nov.

Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics

Shirin Kalimuddin  1   2 , Eng Eong Ooi  2   3   4   5
Affiliations

Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics

Shirin Kalimuddin et al. PLoS Biol. .

Abstract

The COVID-19 pandemic has accelerated the development of vaccines for viral infections. However, a failure to integrate T cell immunity as a determinant of vaccine efficacy could curtail advancement of newer vaccines for pandemic preparedness.

PubMed Disclaimer

Conflict of interest statement

I have read the journal’s policy and the authors of this manuscript have the following competing interests: EEO is a member of the Advisory Board of Arcturus Therapeutics, and has served in advisory capacities on dengue for Sanofi Pasteur, Takeda, Johnson & Johnson and Novartis. SK has served as an advisor on dengue for Takeda and Johnson & Johnson.

References

    1. Usher AD. CEPI launches 100-day vaccine “moonshot”. Lancet. 2022;399:1107–1108. doi: 10.1016/S0140-6736(22)00513-x - DOI - PMC - PubMed
    1. Kalimuddin S, Tham CYL, Qui M, de Alwis R, Sim JXY, Lim JME, et al. Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. Med. 2021;2:682–688.e4. doi: 10.1016/j.medj.2021.04.003 - DOI - PMC - PubMed
    1. Vardhana S, Baldo L, Morice WG, Wherry EJ. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022;7:eabo1303. doi: 10.1126/sciimmunol.abo1303 - DOI - PMC - PubMed
    1. Zhang Z, Mateus J, Coelho CH, Dan JM, Moderbacher CR, Gálvez RI, et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185:2434–2451.e17. doi: 10.1016/j.cell.2022.05.022 - DOI - PMC - PubMed
    1. Premikha M, Chiew CJ, Wei WE, Leo YS, Ong B, Lye DC, et al. Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore. Clin Infect Dis. 2022;75:1442–1445. doi: 10.1093/cid/ciac288 - DOI - PMC - PubMed